Ebola Vaccine Trial for Bundibugyo Strain Begins in DR Congo
The 'Tumaini' clinical trial, a Phase 2/3 study for Bundibugyo Ebola vaccine candidates, launched in Bunia, Democratic Republic of Congo, with its first participant vaccinated.
PrimaryBrief newsroom36 sources